Patents by Inventor George Gutman

George Gutman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7378496
    Abstract: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KCNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: May 27, 2008
    Assignee: The Regents of the University of California
    Inventors: K. George Chandy, J. Jay Gargus, George Gutman, Emmanuelle Fantino, Katarin Kalman
  • Patent number: 7120224
    Abstract: An x-ray imaging apparatus for mammography. The apparatus places the focal spot of the x-ray source as close as possible to a compression paddle or into a desired region of tissue. The apparatus comprises an x-ray source, a collimator with conditioning optics which focus and direct x-ray radiation to a metal pseudo-target in the collimator or a needle placed along the x-ray beam, paddles for breast compression and a detector. The pseudo-target re-emits monochromatic x-ray radiation with an energy, intensity, and space distribution that are adjustable in accordance with a desired imaging procedure.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: October 10, 2006
    Assignee: Advanced X-Ray Technology, Inc.
    Inventor: George Gutman
  • Publication number: 20060133575
    Abstract: The invention is directed to an x-ray device and method for radiation treatment comprising an x-ray source 1, a collimator 4 incorporating conditional optics, such as a capillary lens 3 for directing and focusing the x-ray radiation, and implantable needles. One or more capillary semilenses 16, 17 are positioned along the optical axis of the x-ray beam allow to form a movable focus by changing the distance between the semilenses. The input end of the collimator 4 is optically and mechanically conjugated with the x-ray source 1. The output end of the collimator is optically and mechanically conjugated with an originating end of the needle 5. At its output end is a transparent window 6 on which can repose a layer 13 that substantially absorbs and re-emits radiation which passes through the window 6.
    Type: Application
    Filed: July 27, 2005
    Publication date: June 22, 2006
    Applicant: Advanced X-Ray Technology, Inc.
    Inventors: George Gutman, Emil Strumban
  • Publication number: 20060093084
    Abstract: An x-ray imaging apparatus for mammography. The apparatus places the focal spot of the x-ray source as close as possible to a compression paddle or into a desired region of tissue. The apparatus comprises an x-ray source, a collimator with conditioning optics which focus and direct x-ray radiation to a metal pseudo-target in the collimator or a needle placed along the x-ray beam, paddles for breast compression and a detector. The pseudo-target re-emits monochromatic x-ray radiation with an energy, intensity, and space distribution that are adjustable in accordance with a desired imaging procedure.
    Type: Application
    Filed: October 25, 2005
    Publication date: May 4, 2006
    Applicant: Advanced X-Ray Technology, Inc.
    Inventor: George Gutman
  • Publication number: 20050082698
    Abstract: The present invention provides a method and apparatus for the continuous manufacturing of optical memory or optical memory substrates, and/or optical disks, which includes supplying a web of material to a substrate forming apparatus, embossing a microform image onto a polymeric film, such as an information track structure for an optical device, onto one or both sides of the web with a flat stamper and punching a hole through the web during the embossing. During the embossing, the polymeric material is heated to above the glass transition temperature (Tg). A flat stamper limits the potential for warp in the web, particularly when the web is stabilized in the stamp zone. The disclosed invention is particularly useful in the production of optical disk substrates, such as polycarbonate, having a thickness of 0.6 mm or less.
    Type: Application
    Filed: June 20, 2003
    Publication date: April 21, 2005
    Inventors: George Gutman, Michael Hennessey, Barry Clark, David Strand
  • Publication number: 20040150135
    Abstract: The present invention provides a method for the continuous manufacturing of optical memory or optical memory substrates, and/or optical disks, which includes supplying a web of polymeric material between two mating platens, melt-forming at least one microform image, such as an information track structure for an optical device, into the web with a substantially flat stamper, heating a substantial portion of the melt formed cross section of the web of polymeric material to the melt flow temperature (Tf) of the polymeric material. The invention discloses several embodiments for melt-forming an information structure and depositing several layers onto information structure to produce an optical memory device.
    Type: Application
    Filed: June 19, 2003
    Publication date: August 5, 2004
    Inventors: Michael Hennessey, George Gutman, David Strand, Barry Clark
  • Publication number: 20040137487
    Abstract: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KCNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided.
    Type: Application
    Filed: November 24, 2003
    Publication date: July 15, 2004
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: K. George Chandy, J. Jay Gargus, George Gutman, Emmanuelle Fantino, Katarin Kalman
  • Patent number: 6653100
    Abstract: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KCNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: November 25, 2003
    Assignee: The Regents of the University of California
    Inventors: K. George Chandy, J. Jay Gargus, George Gutman, Emmanuelle Fantino, Katarin Kalman
  • Patent number: 6580940
    Abstract: An x-ray system for treatment cancer by delivering x-ray radiation directly to a desired region of tissue comprising an x-ray source with directed narrow space distribution of x-rays (linear accelerator), conditioning optics which direct and monochromotize x-ray radiation, an implantable needle with means for shaping beam installed across the x-ray beam, and expanding pipe-guide connecting conditioning optics with implantable needle whereby the energy, intensity, and space distribution of the delivered to the tumor x-ray radiation may be adjusted in accordance with the predefined treatment requirements.
    Type: Grant
    Filed: February 2, 2001
    Date of Patent: June 17, 2003
    Inventor: George Gutman
  • Patent number: 6493421
    Abstract: An X-ray source is provided for delivering a high intensity X-ray beam with a predefined energy level of monochromatization, intensity and spatial distribution to a desired region of a sample. The source includes a linear accelerator with a thin anode 4, an electron trap 5 for separating an electron beam from an X-ray beam and conditioning optics which direct, shape and monochromatize the X-ray beam. The conditioning optics include a housing 8 within which are contained entrance slits, multi layer Kirkpatrick-Baez mirrors, exit slits, and a stop diaphragm. The invention also include a method of generating X-rays and a method of using them.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: December 10, 2002
    Assignee: Advanced X-Ray Technology, Inc.
    Inventor: George Gutman
  • Publication number: 20020064253
    Abstract: An X-ray source is provided for delivering a high intensity X-ray beam with a predefined energy level of monochromatization, intensity and spatial distribution to a desired region of a sample. The source includes a linear accelerator with a thin anode 4, an electron trap 5 for separating an electron beam from an X-ray beam and conditioning optics which direct, shape and monochromatize the X-ray beam. The conditioning optics include a housing 8 within which are contained entrance slits, multi layer Kirkpatrick-Baez mirrors, exit slits, and a stop diaphragm. The invention also include a method of generating X-rays and a method of using them.
    Type: Application
    Filed: October 9, 2001
    Publication date: May 30, 2002
    Applicant: Advanced X-Ray Technology, Inc.
    Inventor: George Gutman
  • Publication number: 20020003856
    Abstract: An x-ray system for treatment cancer by delivering x-ray radiation directly to a desired region of tissue comprising an x-ray source with directed narrow space distribution of x-rays (linear accelerator), conditioning optics which direct and monochromotize x-ray radiation, an implantable needle with means for shaping beam installed across the x-ray beam, and expanding pipe-guide connecting conditioning optics with implantable needle whereby the energy, intensity, and space distribution of the delivered to the tumor x-ray radiation may be adjusted in accordance with the predefined treatment requirements.
    Type: Application
    Filed: February 2, 2001
    Publication date: January 10, 2002
    Inventor: George Gutman
  • Patent number: 6165719
    Abstract: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided.
    Type: Grant
    Filed: July 14, 1998
    Date of Patent: December 26, 2000
    Assignee: The Regents of the University of California
    Inventors: K. George Chandy, J. Jay Gargus, George Gutman, Emmanuelle Fantino, Katarin Kalman
  • Patent number: 6041099
    Abstract: An x-ray reflecting system comprising a Kirkpatrick-Baez side-by-side optic in a single corner configuration having multi-layer Bragg x-ray reflective surfaces.
    Type: Grant
    Filed: February 19, 1998
    Date of Patent: March 21, 2000
    Assignee: Osmic, Inc.
    Inventors: George Gutman, Licai Jiang, Boris Verman
  • Patent number: 6014423
    Abstract: An x-ray reflecting system comprising a plurality of x-ray reflectors, wherein the x-ray reflectors are coupled together to form a Kirkpatrick-Baez side-by-side system of multiple corners and may include multi-layer or graded-d multi-layer Bragg x-ray reflective surfaces.
    Type: Grant
    Filed: February 19, 1998
    Date of Patent: January 11, 2000
    Assignee: OSMIC, Inc.
    Inventors: George Gutman, Licai Jiang, Boris Verman
  • Patent number: 5827655
    Abstract: This disclosure relates to the n K.sup.+ channel expression product of the MK3 gene or a functionally bioactive equivalent thereof and its uses, particulary in combination with identifying immune responses and materials modulating or blocking same.
    Type: Grant
    Filed: September 12, 1995
    Date of Patent: October 27, 1998
    Assignee: The Regents of the University of California
    Inventors: Kanianthara G. Chandy, Michael D. Cahalan, Stephan Grissmer, Alan L. Goldin, Brent A. Dethlefs, George A. Gutman, John J. Wasmuth
  • Patent number: 5799056
    Abstract: This invention relates to novel methods of producing flat and curved optical elements with laterally and depth graded multilayer thin films, in particular multilayers of extremely high precision, for use with soft and hard x-rays and neutrons and the optical elements achieved by these methods. In order to improve the performance of an optical element, errors in d spacing and curvature are isolated and subsequently compensated.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: August 25, 1998
    Assignee: Ovonic Synthetic Materials Company, Inc.
    Inventor: George Gutman
  • Patent number: 5757882
    Abstract: An optical system for providing a steerable monochromatized source of x-ray or neutron radiation. The system incorporates a radiation source and a Bragg structure reflective optical element. A stage causes the optical element to move relative to the radiation source. Such movement is coordinated with lateral d-layer grading such that Bragg's law of reflection is satisfied for radiation of a given wavelength bandwidth to be reflected at various instances and departure angles.
    Type: Grant
    Filed: December 18, 1995
    Date of Patent: May 26, 1998
    Assignee: Osmic, Inc.
    Inventor: George Gutman
  • Patent number: 5646976
    Abstract: This invention relates to novel methods of producing flat and curved optical elements with laterally and depth graded multilayer thin films, in particular multilayers of extremely high precision, for use with soft and hard x-rays and neutrons and the optical elements achieved by these methods. In order to improve the performance of an optical element, errors in d spacing and curvature are isolated and subsequently compensated.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 8, 1997
    Assignee: Osmic, Inc.
    Inventor: George Gutman
  • Patent number: 5559009
    Abstract: This disclosure relates to the identification of a new voltage-gated potassium channel gene, Kv1.7, which is expressed in pancreatic .beta.-cells. The invention utilizes this new potassium channel for assays designed to identify extrinsic materials with the ability to modulate said channel for the development of therapeutics effective in the treatment of non-insulin-dependent diabetes mellitus.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: September 24, 1996
    Assignee: The Regents of The University of California
    Inventors: Kanianthara G. Chandy, Katalin Kalman, Grischa Chandy, George A. Gutman